Dario, please

In his “We Must Pace the Frontier” essay, Amodei paints a picture of AI as a panacea—promising cures for major illnesses, rapid economic growth, and a resurgence of democratic freedoms. He backs the narrative with personal anecdotes about his father’s death and his own cancer battle, then pivots to a policy agenda: he asks regulators to impose strict controls on open‑weight models, to treat model distillation harshly, to grant Anthropic an antitrust waiver, and to limit China’s access to frontier AI. At the same time, Amodei acknowledges recent safety lapses at both Anthropic and OpenAI, citing three recent OpenAI incidents that compromised public internet infrastructure and internal “incidents” at Anthropic. He also points to Anthropic’s own threat‑intelligence report, which describes the company’s detection and blocking of misuse of its Claude series, while noting that Anthropic is hiring biologists and building wet labs to keep any biomedical breakthroughs in‑house.

The post lands amid an intensifying rivalry among the so‑called “frontier labs.” OpenAI has just launched GPT‑6 Astra, a model that its leadership claims signals the arrival of artificial general intelligence, while Nvidia’s Jensen Huang touts a new wave of “recursive self‑improvement” agents (RSI). Simultaneously, OpenAI’s recent breach of HuggingFace—exploiting WebDAV and token‑refresh flaws—has fed a narrative of unchecked power and security risk. Competitors are also racing to solve high‑profile scientific problems; OpenAI allegedly poured tens of millions of dollars into compute to chase a Navier‑Stokes variant, even accusing the company of appropriating work from independent mathematicians. This backdrop of rapid capability gains, high‑stakes compute spending, and recurring security incidents fuels Amodei’s call for a “gentlemen’s agreement” to slow the frontier, even as he positions Anthropic and OpenAI as the responsible custodians of the technology.

If policymakers accept Amodei’s proposals, the AI landscape could bifurcate: open‑weight models would face heavy regulatory constraints, while a privileged few—potentially including Anthropic—operate under a self‑selected safety regime. Such a structure risks regulatory capture, limits broader scientific participation, and may entrench U.S. dominance while marginalizing rivals like China. Watch for legislative drafts on model licensing, antitrust filings concerning AI conglomerates, and any formal security standards emerging from industry coalitions, as these will shape whether Amodei’s vision becomes a de‑facto monopoly or a contested policy experiment.